Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DMIIU

Drugs Made In America Acquisition II Corp.

CIK 0002040475 · Nasdaq

NasdaqFinancialsBlank Checks
$10.16
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$647.19M
P/E Ratio
Not covered
EPS
Not covered
Dividend Yield
Not covered
52W Position
26%
Beta
0.02

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-36.33
P/S
Not covered
EV/Revenue
Not covered
ROE
-48.2%
Valuation data covers 8,494/9,463 US-listed stocks (89.8%).

Price · 1Y

197 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 26%
$9.94$10.80

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$4.19M
Total Assets
$504.96M
Free Cash Flow
–

Recent news